Vermont Disclosure

Information for Vermont Prescribers of Prescription Drugs Provided Pursuant to Vermont's Pharmaceutical Marketer Price Disclosure Law

This information is intended for Vermont Prescribers.

33 V.S.A. § 2005a.

Product Name Short Form Long Form Date updated
Aubagio® (teriflunomide) Aubagio Short Form Aubagio Long Form October 21, 2019
Avalide® (irbesartan and hydrochlorothiazide) Avalide Short Form Avalide Long Form October 29, 2019
Avapro® (irbesartan) Avapro Short Form Avapro Long Form October 29, 2019
Cerdelga (eliglustat) Cerdelga Short Form Cerdelga Long Form October 21, 2019
Multaq (dronedarone) Multaq Short Form Multaq Long Form October 21, 2019
Renvela (sevelamer carbonate) Renvela Short Form Renvela Long Form October 21, 2019
Caprelsa (vandetanib) Caprelsa Short Form Caprelsa Long Form October 21, 2019

Guide to Vermont's Pharmaceutical Marketer Price Disclosure Law, 33 V.S.A. § 2005a. Published by the Vermont Office of the Attorney General.

Please See Full Prescribing Information, including Boxed Warning, for Avalide, AvaproAubagio, Caprelsa and Multaq.